Health Insurance Bureau issued a guidance directory: check drug prices, drug companies costs...

Medical Network September 10, the State Health Insurance Administration issued a directory of administrative law enforcement guidance, involving drug price monitoring, cost investigation and other content guidance directory published, the Health Insurance Bureau has the right to do these things on September 7, the State Health Insurance Administration issued the "Medical Security Administrative Law Enforcement Matters Guidance Directory", and in the same day's notice requires all levels of health insurance directory in accordance with the guidance directory to carry out daily work, at the same time, all places in the medical insurance administrative law enforcement process encountered in a timely manner to report to the higher level of health insurance administrative departments.
, the guidance directory involves a total of 15 items, divided into the name of the matter, the type of authority, the basis for implementation and the implementation of the main body 4 major parts.
of the 15 items, 7 are administrative inspections, 6 are administrative penalties and 2 are other administrative powers and administrative coercion, respectively.
China Medical Insurance points out in the article that administrative law enforcement is an important way for administrative organs to perform government functions and manage economic and social affairs.
"Guidance Directory" clearly defines the powers and responsibilities of the administrative law enforcement of the local medical insurance departments, in particular, gives a clear legal basis, and is expected to solve the difficulties encountered in the administrative law enforcement of the local medical insurance departments to a great extent, and enhance the authority of the administrative law enforcement of medical insurance.
drug price monitoring and cost investigation focus on the 15 items listed in the guidance catalogue, there are many contents related to drug price supervision and drug tender procurement.
8 of the Guidance Directory stipulates that medical insurance departments at all levels may conduct monitoring and cost investigations on the prices of medicines and medical supplies.
In accordance with Article 103 of the Basic Health Care and Health Promotion Act, if, in violation of the provisions of this Law, bidders participating in drug procurement tenders bid at a lower cost, or by means of fraud, bid rigging, abuse of market dominance, etc., shall be ordered by the competent department of medical security of the people's government at or above the county level to correct and confiscate the illegal proceeds; If the winning bid is invalid, a fine of not more than five thousandths of the winning project shall be imposed, and the legal representative, the principal person in charge, the person in charge directly responsible and other responsible personnel shall be fined not less than five percent of the amount of the unit's fine;
Article 9 of the guidance catalogue stipulates that medical insurance departments at all levels may supervise and inspect the licensed holders of medicines, pharmaceutical and medical supplies production enterprises, pharmaceutical operating enterprises and medical institutions to the competent departments of pharmaceutical prices the actual purchase and sale prices of their medicines and medical supplies and the quantity purchased and sold, and Article 11 of the guidance catalogue stipulates that medical insurance departments at all levels shall have the right to supervise and inspect the centralized procurement of medicines and high-value medical supplies by public medical institutions.
12 of the Catalogue of Guidance further stipulates that medical insurance departments at all levels shall have the right to supervise and manage the illegal acts committed by bidders participating in tenders for drug procurement.
In accordance with Article 103 of the Basic Health Care and Health Promotion Act, if, in violation of the provisions of this Law, bidders participating in drug procurement tenders bid at a lower cost, or by means of fraud, bid rigging, abuse of market dominance, etc., shall be ordered by the competent department of medical security of the people's government at or above the county level to correct and confiscate the illegal proceeds; If the winning bid is invalid, a fine of not more than five thousandths of the winning project shall be imposed, and the legal representative, the principal person in charge, the person in charge directly responsible and other responsible personnel shall be fined not less than five percent of the amount of the unit's fine;
Health Insurance Bureau this time in the form of a guidance directory to clarify the implementation of the above-mentioned matters and the implementation agencies, it seems to reveal that the above-mentioned work has become the focus of the Health Insurance Bureau, as well as the daily focus of the health care departments at all levels.
.